About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 401 record(s)
Req # A-2020-0012
Information about CIHR Project grants #156154 and #391917Organization: Canadian Institutes of Health Research
September 2020
Req # A-2020-0017
Briefing notes #21636374, #21380817, #2020-0050, #21505789 and #21189022.Organization: Canadian Institutes of Health Research
September 2020
Req # A-2020-0020
Information related CIHR contract/solicitation TBIPS-CIHR-CCV-02-2017.Organization: Canadian Institutes of Health Research
September 2020
Req # A-2020-0023
All expenses with the 2020/2021 object codes 1231, 1246, and 0533Organization: Canadian Institutes of Health Research
September 2020
Req # A-2020-00004
List of mandatory or voluntary training, info sessions, awareness sessions, and sensitivity training from January 1, 2020 to September 2020.Organization: Patented Medicine Prices Review Board Canada
September 2020
Req # A-2020-04135
Copies of the Human Drug Advisory (HDAP) report for erenumab (Aimovig) from January 2018 to February 2020.Organization: Patented Medicine Prices Review Board Canada
September 2020
Req # A-2020-09098
Copies of all records discussing the impacts of the regulatory changes to the PMPRB from August 2019 until August 2020. Copies of all correspondence from all pharmaceutical companies expressing their concerns with the changes and any responses back to these companies. Copies of all correspondence from all advocating groups expressing concerns with the changes and any responses back to these groups. Copies of all correspondence between departmental staff discussing the impacts of the regulatory changes to the PMPRB. Copies of all records discussing the impacts of the PMPRB changes on individuals living with rare diseases. Copies of all correspondence from Vertex Pharmaceuticals relating to Kalydeco, Orkambi, Symdeko, and Trikafta. Copies of all correspondence between government officials (Prime Minister, Ministers, all members of parliament, constituency staff, deputies, assistant deputies, directors, managers, supervisors, staff, and any other employee of the Government of Canada relating to the PMPRB regulatory changes. Copies of all presentations relating to the PMPRB regulatory changes.Organization: Patented Medicine Prices Review Board Canada
September 2020
Req # A-2019-00025
Briefing notes for AECL Board of Directors relating to the Performance Evaluation and Measure PlanOrganization: Atomic Energy of Canada Limited
August 2020
Req # A-2020-0018
Records regarding this article in The Logic/business relations between CIHR and Palantir.Organization: Canadian Institutes of Health Research
August 2020
Req # A-2020-0010
Records held by CIHR pertaining to all funding competitions and corresponding grants, awards, and contracts allocated by CIHR between January 1, 2020 and May 3, 2020Organization: Canadian Institutes of Health Research
August 2020